AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 17167156 — intervention group
Group type: COMPARATOR
Intervention: Successful aging (SA) health education intervention
Number of subjects: 424
Study 12881377 — intervention group
Group type: EXPERIMENTAL
Intervention: Mammography
Number of subjects: 0
Study 12881377 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical examination
Number of subjects: 0
Study 12881377 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of mammography and physical examination
Number of subjects: 0
Study 12881377 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 10761786 — intervention group
Group type: EXPERIMENTAL
Intervention: Elective (immediate) lymph node dissection (ELND)
Number of subjects: 740
Study 10761786 — intervention group
Group type: COMPARATOR
Intervention: Nodal observation
Number of subjects: 740
Study 8826153 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofeedback treatment (10 weekly sessions of 15 minutes' duration)
Number of subjects: 27
Study 7948812 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastroenterologists
Number of subjects: 313
Study 7948812 — intervention group
Group type: COMPARATOR
Intervention: Internists
Number of subjects: 313
Study 7948812 — intervention group
Group type: COMPARATOR
Intervention: Gastroenterology nurses
Number of subjects: 313
Study 7948812 — intervention group
Group type: COMPARATOR
Intervention: General nurses
Number of subjects: 313
Study 7948812 — intervention group
Group type: COMPARATOR
Intervention: Controls
Number of subjects: 313
Study 3582466 — intervention group
Group type: EXPERIMENTAL
Intervention: Enprofylline (1 mg/kg body weight over 10 min) with terbutaline pretreatment (4 micrograms/kg body weight)
Number of subjects: 16
Study 3582466 — intervention group
Group type: COMPARATOR
Intervention: Enprofylline (1 mg/kg body weight over 10 min) with placebo pretreatment
Number of subjects: 16
Study 31518475 — intervention group
Group type: EXPERIMENTAL
Intervention: Flipped classroom method (n=31)
Number of subjects: 61
Study 31518475 — intervention group
Group type: COMPARATOR
Intervention: Conventional teaching method (n=30)
Number of subjects: 61
Study 30289578 — intervention group
Group type: EXPERIMENTAL
Intervention: Tablet-based application (eMedHAT)
Number of subjects: 220
Study 30289578 — intervention group
Group type: COMPARATOR
Intervention: Structured interview (MedHAT)
Number of subjects: 220
Study 28858247 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic (10⁸ CFUs of L. reuteri DSM 17938)
Number of subjects: 100
Study 28858247 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 24476783 — intervention group
Group type: EXPERIMENTAL
Intervention: Plyometric Training Group (PTG)
Number of subjects: 22
Study 24476783 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 22
Study 22520664 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy eating counselling
Number of subjects: 23
Study 22520664 — intervention group
Group type: COMPARATOR
Intervention: Smoking cessation counselling
Number of subjects: 23
Study 20718754 — intervention group
Group type: EXPERIMENTAL
Intervention: Aprepitant 40/25mg (40mg on day 1 and 25mg on days 2-5)
Number of subjects: 453
Study 20718754 — intervention group
Group type: EXPERIMENTAL
Intervention: Aprepitant 125/80mg (125mg on day 1 and 80mg on days 2-5)
Number of subjects: 453
Study 20718754 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy (granisetron and dexamethasone)
Number of subjects: 453
Study 17716750 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment group (40 children)
Number of subjects: 73
Study 17716750 — intervention group
Group type: COMPARATOR
Intervention: Control group (29 children)
Number of subjects: 73
Study 15817818 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel (300‐mg loading dose and 75‐mg maintenance dose)
Number of subjects: 24
Study 15817818 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 12080483 — intervention group
Group type: EXPERIMENTAL
Intervention: Levonorgestrel-releasing intrauterine device (20 microgram/day)
Number of subjects: 72
Study 12080483 — intervention group
Group type: COMPARATOR
Intervention: Thermal balloon ablation
Number of subjects: 72
Study 12080483 — intervention group
Group type: EXPERIMENTAL
Intervention: Levonorgestrel-releasing intrauterine device
Number of subjects: 72
Study 9882033 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg o.m. pantoprazole
Number of subjects: 64
Study 9882033 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg o.m. pantoprazole
Number of subjects: 64
Study 9882033 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg b.d. pantoprazole
Number of subjects: 64
Study 7801663 — intervention group
Group type: EXPERIMENTAL
Intervention: Special mechanical device for compression dressing
Number of subjects: 500
Study 7801663 — intervention group
Group type: COMPARATOR
Intervention: Conventional pressure dressing
Number of subjects: 500
Study 2898901 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 micrograms sufentanil
Number of subjects: 22
Study 2898901 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 micrograms sufentanil
Number of subjects: 22
Study 2898901 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 micrograms sufentanil
Number of subjects: 22
Study 2898901 — intervention group
Group type: COMPARATOR
Intervention: No drug (control group IV)
Number of subjects: 22
Study 31505002 — intervention group
Group type: EXPERIMENTAL
Intervention: Web platform
Number of subjects: 462
Study 31505002 — intervention group
Group type: COMPARATOR
Intervention: Genetic counselor
Number of subjects: 462
Study 31505002 — intervention group
Group type: EXPERIMENTAL
Intervention: Both arms (web platform and genetic counselor)
Number of subjects: 462
Study 29924768 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous dental pulp mesenchymal stem cells in a collagen matrix
Number of subjects: 32
Study 29924768 — intervention group
Group type: COMPARATOR
Intervention: Collagen matrices alone (Control)
Number of subjects: 32
Study 28739782 — intervention group
Group type: EXPERIMENTAL
Intervention: PZA (10 or 25 mg/kg) plus allopurinol (100 mg daily)
Number of subjects: 0
Study 28739782 — intervention group
Group type: COMPARATOR
Intervention: PZA alone
Number of subjects: 0
Study 28739782 — intervention group
Group type: EXPERIMENTAL
Intervention: PZA plus allopurinol
Number of subjects: 0
Study 26650493 — intervention group
Group type: EXPERIMENTAL
Intervention: AMSA injection
Number of subjects: 30
Study 26650493 — intervention group
Group type: COMPARATOR
Intervention: Supraperiosteal injection
Number of subjects: 30
Study 23358899 — intervention group
Group type: EXPERIMENTAL
Intervention: 6× hemodialysis
Number of subjects: 0
Study 23358899 — intervention group
Group type: COMPARATOR
Intervention: 3× hemodialysis
Number of subjects: 0
Study 21610860 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle counseling intervention
Number of subjects: 399
Study 21610860 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 399
Study 18477346 — intervention group
Group type: EXPERIMENTAL
Intervention: Tegaserod 6 mg twice daily
Number of subjects: 661
Study 18477346 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 661
Study 16507848 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast (n=1,439)
Number of subjects: 3073
Study 16507848 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone (n=894)
Number of subjects: 3073
Study 16507848 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=740)
Number of subjects: 3073
Study 12686231 — intervention group
Group type: EXPERIMENTAL
Intervention: Tecnis Z9000 IOL
Number of subjects: 45
Study 12686231 — intervention group
Group type: COMPARATOR
Intervention: SI-40 IOL
Number of subjects: 45
Study 11093995 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.2%
Number of subjects: 50
Study 11093995 — intervention group
Group type: COMPARATOR
Intervention: Control Group (sterile water)
Number of subjects: 50
Study 9401313 — intervention group
Group type: EXPERIMENTAL
Intervention: Augmentation therapy with triiodothyronine (T3)
Number of subjects: 0
Study 9401313 — intervention group
Group type: COMPARATOR
Intervention: Substitution therapy (replacing one antidepressant with another)
Number of subjects: 0
Study 9401313 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (adding a second antidepressant to the first)
Number of subjects: 0
Study 1420630 — intervention group
Group type: EXPERIMENTAL
Intervention: Marijuana smoking
Number of subjects: 10
Study 1420630 — intervention group
Group type: COMPARATOR
Intervention: Placebo smoking
Number of subjects: 10
Study 3900457 — intervention group
Group type: EXPERIMENTAL
Intervention: TMS-19-Q.GC tablet (TMS)
Number of subjects: 154
Study 3900457 — intervention group
Group type: COMPARATOR
Intervention: Josamycin tablet (JM)
Number of subjects: 154
Study 31685516 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefazolin plus vancomycin
Number of subjects: 4450
Study 31685516 — intervention group
Group type: COMPARATOR
Intervention: Cefazolin plus placebo
Number of subjects: 4450
Study 30302557 — intervention group
Group type: EXPERIMENTAL
Intervention: Bacterial cellulose wound dressing containing silk sericin and polyhexamethylene biguanide (BCSP)
Number of subjects: 21
Study 30302557 — intervention group
Group type: COMPARATOR
Intervention: Bactigras® (control)
Number of subjects: 21
Study 27509600 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture method of 'Huoxue Sanfeng, Shugan Jianpi'
Number of subjects: 68
Study 27509600 — intervention group
Group type: COMPARATOR
Intervention: Acupuncture method of 'Xingnao Kaiqiao' and oral administration of nifedipine (Control group)
Number of subjects: 68
Study 24121242 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational self-talk (ST)
Number of subjects: 24
Study 24121242 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 24
Study 22669570 — intervention group
Group type: EXPERIMENTAL
Intervention: Ridaforolimus 40 mg in fasted state
Number of subjects: 18
Study 22669570 — intervention group
Group type: EXPERIMENTAL
Intervention: Ridaforolimus 40 mg with light breakfast
Number of subjects: 18
Study 22669570 — intervention group
Group type: EXPERIMENTAL
Intervention: Ridaforolimus 40 mg with high-fat breakfast
Number of subjects: 18
Study 20925587 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention
Number of subjects: 0
Study 20925587 — intervention group
Group type: COMPARATOR
Intervention: Coronary artery bypass grafting
Number of subjects: 0
Study 16934490 — intervention group
Group type: EXPERIMENTAL
Intervention: Judgements of intentions
Number of subjects: 0
Study 16934490 — intervention group
Group type: EXPERIMENTAL
Intervention: Unpredictable judgement conditions
Number of subjects: 0
Study 16934490 — intervention group
Group type: COMPARATOR
Intervention: Control task (reporting time of tones)
Number of subjects: 0
Study 16934490 — intervention group
Group type: EXPERIMENTAL
Intervention: Deafferented subject IW
Number of subjects: 0
Study 16274475 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus reuteri (108 Colony Forming Units daily for 80 days)
Number of subjects: 262
Study 16274475 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 262
Study 16274475 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus reuteri
Number of subjects: 262
Study 12239690 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 5 mg
Number of subjects: 120
Study 12239690 — intervention group
Group type: COMPARATOR
Intervention: Tropisetron 2 mg
Number of subjects: 120
Study 12239690 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 120
Study 10519348 — intervention group
Group type: EXPERIMENTAL
Intervention: Early discharge group (EDG) with domiciliary nursing care
Number of subjects: 88
Study 10519348 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) with standard neonatal care
Number of subjects: 88
Study 10519348 — intervention group
Group type: EXPERIMENTAL
Intervention: Early discharge group (EDG)
Number of subjects: 88
Study 10519348 — intervention group
Group type: COMPARATOR
Intervention: Both groups (EDG and CG)
Number of subjects: 88
Study 10155659 — intervention group
Group type: EXPERIMENTAL
Intervention: Integration of health promotion and health protection through joint worker-management participation, consultation on worksite changes, and educational programs targeting health behavior change.
Number of subjects: 24
Study 2043298 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 24
Study 2043298 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 24
Study 6461999 — intervention group
Group type: EXPERIMENTAL
Intervention: d‐tubocurarine (0.05 mg/kg)
Number of subjects: 60
Study 6461999 — intervention group
Group type: EXPERIMENTAL
Intervention: alcuronium (0.03 mg/kg)
Number of subjects: 60
Study 6461999 — intervention group
Group type: EXPERIMENTAL
Intervention: pancuronium (0.008 mg/kg)
Number of subjects: 60
Study 6461999 — intervention group
Group type: COMPARATOR
Intervention: saline
Number of subjects: 60
Study 31348595 — intervention group
Group type: EXPERIMENTAL
Intervention: Emicizumab prophylaxis
Number of subjects: 11
Study 28219058 — intervention group
Group type: EXPERIMENTAL
Intervention: Cupping massage
Number of subjects: 50
Study 28219058 — intervention group
Group type: COMPARATOR
Intervention: Wait list control
Number of subjects: 50
Study 25679747 — intervention group
Group type: EXPERIMENTAL
Intervention: Study diet (n=10) containing alpha-casozepine and tryptophan, fed for 8 weeks
Number of subjects: 21
Study 25679747 — intervention group
Group type: COMPARATOR
Intervention: Control diet (n=11), fed for 8 weeks
Number of subjects: 21
Study 25679747 — intervention group
Group type: EXPERIMENTAL
Intervention: Study diet (n=10)
Number of subjects: 21
Study 23769246 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac 1 mg/kg
Number of subjects: 56
Study 23769246 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoprofen 100 mg
Number of subjects: 56
Study 23769246 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoprofen 50 mg + 50 mg tramadol
Number of subjects: 56
Study 23769246 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoprofen 100 mg + 100 mg tramadol
Number of subjects: 56
Study 21208398 — intervention group
Group type: EXPERIMENTAL
Intervention: Anthelmintic treatment programme (oral ivermectin and fenbendazole)
Number of subjects: 239
Study 21208398 — intervention group
Group type: COMPARATOR
Intervention: Placebo control
Number of subjects: 239
Study 19798415 — intervention group
Group type: EXPERIMENTAL
Intervention: PfCS102 with AS02A (30 microg)
Number of subjects: 36
Study 19798415 — intervention group
Group type: EXPERIMENTAL
Intervention: PfCS102 with AS02A (100 microg)
Number of subjects: 36
Study 19798415 — intervention group
Group type: COMPARATOR
Intervention: PfCS102 with Montanide ISA 720 (30 microg)
Number of subjects: 36
Study 19798415 — intervention group
Group type: COMPARATOR
Intervention: PfCS102 with Montanide ISA 720 (100 microg)
Number of subjects: 36
Study 19798415 — intervention group
Group type: EXPERIMENTAL
Intervention: PfCS102 with AS02A (10 microg)
Number of subjects: 36
Study 16718798 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mL epinephrine
Number of subjects: 228
Study 16718798 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mL epinephrine
Number of subjects: 228
Study 16718798 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mL epinephrine
Number of subjects: 228
Study 15290120 — intervention group
Group type: EXPERIMENTAL
Intervention: CRT ON
Number of subjects: 10
Study 15290120 — intervention group
Group type: COMPARATOR
Intervention: CRT OFF
Number of subjects: 10
Study 11513170 — intervention group
Group type: EXPERIMENTAL
Intervention: Eradication treatment (lansoprazole 15 mg b.i.d., amoxicillin 1 g b.i.d., clarithromycin 500 mg b.i.d.)
Number of subjects: 144
Study 11513170 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment (lansoprazole 15 mg b.i.d. and placebo)
Number of subjects: 144
Study 11513170 — intervention group
Group type: EXPERIMENTAL
Intervention: Eradication treatment
Number of subjects: 144
Study 11513170 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 144
Study 9278202 — intervention group
Group type: EXPERIMENTAL
Intervention: Study group received counseling about their medicines and a pharmaceutical care plan.
Number of subjects: 53
Study 9278202 — intervention group
Group type: COMPARATOR
Intervention: Control group received normal discharge information without additional counseling.
Number of subjects: 53
Study 9278202 — intervention group
Group type: EXPERIMENTAL
Intervention: Study group received a domiciliary visit between 7 and 10 days after discharge.
Number of subjects: 53
Study 9278202 — intervention group
Group type: EXPERIMENTAL
Intervention: Study group had unintentional changes to medication found during the visit.
Number of subjects: 53
Study 9278202 — intervention group
Group type: COMPARATOR
Intervention: Control group had unintentional changes to medication found during the visit.
Number of subjects: 53
Study 8305360 — intervention group
Group type: EXPERIMENTAL
Intervention: Double hemibody irradiation (DHBI)
Number of subjects: 55
Study 8305360 — intervention group
Group type: COMPARATOR
Intervention: alpha IFN-2b maintenance therapy post-DHBI
Number of subjects: 55
Study 3524665 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral oestradiol, 2 mg daily plus oestriol, 1 mg daily
Number of subjects: 14
Study 3524665 — intervention group
Group type: COMPARATOR
Intervention: Oral oestradiol, 2 mg daily
Number of subjects: 14
Study 30916364 — intervention group
Group type: EXPERIMENTAL
Intervention: 1g/kg of flaxseeds
Number of subjects: 120
Study 30916364 — intervention group
Group type: EXPERIMENTAL
Intervention: 1g/kg of fenugreek seeds
Number of subjects: 120
Study 30916364 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of 1g/kg flaxseeds and 1g/kg fenugreek seeds
Number of subjects: 120
Study 30916364 — intervention group
Group type: COMPARATOR
Intervention: Control (basal diet without any supplementation)
Number of subjects: 120
Study 30216191 — intervention group
Group type: EXPERIMENTAL
Intervention: Opt-out group (n = 9,556)
Number of subjects: 26556
Study 30216191 — intervention group
Group type: EXPERIMENTAL
Intervention: Opt-in group (n = 14,400)
Number of subjects: 26556
Study 30216191 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 2,600)
Number of subjects: 26556
Study 30216191 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV self-sampling
Number of subjects: 26556
Study 30216191 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV self-sampling in non-attenders screened for more than 10 years
Number of subjects: 26556
Study 26490756 — intervention group
Group type: EXPERIMENTAL
Intervention: Childhood-onset T1DM women
Number of subjects: 214
Study 26490756 — intervention group
Group type: EXPERIMENTAL
Intervention: Adulthood-onset T1DM women
Number of subjects: 214
Study 23080086 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrin glue spray applied to the axillary fossa in 40 patients
Number of subjects: 80
Study 23080086 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment in 40 patients
Number of subjects: 80
Study 22613033 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin nasal spray
Number of subjects: 48
Study 22613033 — intervention group
Group type: COMPARATOR
Intervention: Placebo nasal spray
Number of subjects: 48
Study 20044267 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative chemoradiation (P‐CRT)
Number of subjects: 5
Study 20044267 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 5
Study 17064888 — intervention group
Group type: EXPERIMENTAL
Intervention: Fulvestrant 250mg
Number of subjects: 66
Study 17064888 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study 16279891 — intervention group
Group type: EXPERIMENTAL
Intervention: Urgent colonoscopy
Number of subjects: 100
Study 16279891 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 100
Study 11904128 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil 5 mg
Number of subjects: 36
Study 11904128 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil 10 mg
Number of subjects: 36
Study 11904128 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 10217684 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticoids
Number of subjects: 0
Study 10217684 — intervention group
Group type: EXPERIMENTAL
Intervention: Acyclovir
Number of subjects: 0
Study 10217684 — intervention group
Group type: EXPERIMENTAL
Intervention: Empirical treatment
Number of subjects: 0
Study 8747609 — intervention group
Group type: EXPERIMENTAL
Intervention: Relief Band at P6 acupuncture point
Number of subjects: 9
Study 8747609 — intervention group
Group type: COMPARATOR
Intervention: Placebo site
Number of subjects: 9
Study 8747609 — intervention group
Group type: COMPARATOR
Intervention: Switching to placebo position from P6
Number of subjects: 9
Study 8747609 — intervention group
Group type: EXPERIMENTAL
Intervention: Switching to P6 position from placebo
Number of subjects: 9
Study 2095345 — intervention group
Group type: COMPARATOR
Intervention: Furosemide 40 mg alone (F)
Number of subjects: 12
Study 2095345 — intervention group
Group type: EXPERIMENTAL
Intervention: Furosemide 40 mg and Triamterene 50 mg (F + T)
Number of subjects: 12
Study 2095345 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed combination of Furosemide 40 mg and Triamterene 50 mg (FT)
Number of subjects: 12
Study 351661 — intervention group
Group type: EXPERIMENTAL
Intervention: EMG biofeedback
Number of subjects: 12
Study 351661 — intervention group
Group type: COMPARATOR
Intervention: false‐EMG biofeedback
Number of subjects: 12
Study 30452776 — intervention group
Group type: EXPERIMENTAL
Intervention: CSL112 2 g (n = 6)
Number of subjects: 32
Study 30452776 — intervention group
Group type: EXPERIMENTAL
Intervention: CSL112 6 g (n = 6)
Number of subjects: 32
Study 30452776 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 2)
Number of subjects: 32
Study 30452776 — intervention group
Group type: EXPERIMENTAL
Intervention: CSL112 (both doses)
Number of subjects: 32
Study 28457194 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg ICG administered 3 to 7 hours before imaging
Number of subjects: 28
Study 28457194 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg ICG administered 5 to 25 hours before imaging
Number of subjects: 28
Study 28457194 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg ICG administered up to 3 hours before imaging
Number of subjects: 28
Study 28457194 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg ICG administered up to 5 hours before imaging
Number of subjects: 28